Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GNCA Genocea Biosciences > Detailed Quotes

GNCA Genocea Biosciences

0.0100.0000.00%
Close 10/04 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.010
Volume
0.00
Market Cap
581.96K
P/E(TTM)
Loss
52wk High
1.970
Shares
58.78M
P/E(Static)
Loss
52wk Low
0.008
Float Cap
485.33K
Bid/Ask %
0.00%
Historical High
191.920
Shs Float
49.02M
Volume Ratio
0.00
Historical Low
0.008
Dividend TTM
--
Div Yield TTM
--
P/B
0.05
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Float Cap
485.33K
Bid/Ask %
0.00%
Historical High
191.920
Shs Float
49.02M
Volume Ratio
0.00
Historical Low
0.008
Dividend TTM
--
P/B
0.05
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
0.00%
Avg Price
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
CEO: Mr. William D. Clark
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...